Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN40085050
ISRCTN40085050CompletedNot Applicable

Second Line Agents in Myositis

Arthritis Research Campaign (ARC) (UK)0 sites0 target enrollmentStarted: February 4, 2002Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients with inflammatory myositis

Exclusion Criteria

  • •Not provided at time of registration

Investigators

Sponsor
Arthritis Research Campaign (ARC) (UK)

Similar Trials

Completed
Not Applicable
Dexa-Myositis Trial: treatment of polymyositis and dermatomyositis - dexamethasone versus prednisoneMyositis, dermatomyositis, polymyositisMusculoskeletal DiseasesMyositis
ISRCTN48188950Academic Medical Centre (AMC) (Netherlands)80
Recruiting
Not Applicable
Significance of myositis-specific autoantibodies (MSA) for clinical features in polymyositis/dermatomyositis-associated interstitial lung diseasePolymyositis/dermatomyositis/clinically amyopathic dermatomyositis-associated Interstitial lung disease
JPRN-UMIN000022605Hamamatsu University School of Medicine100
Recruiting
Not Applicable
Dexa-Myositis Trial.
NL-OMON2581780
Completed
Phase 2
Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant DermatomyositisDermatomyositis, Adult Type
NCT03529955Tulane University8
Recruiting
Not Applicable
IVIG in myositis: TIME IS MUSCLE (TIM)
NL-OMON26160Prinses Beatrix spierfonds, Sanquin Plasma Products48